Instruction for the Injection: It is an intravenous or intramuscular injection taken 1 set per week for 2 months and then it is reduced to 1 set every two weeks
Glucagon-like peptide-1 receptor agonists increase solid gastric residue rates on upper endoscopy especially in patients with complicated diabetes: a case-control study
Patients with concomitant obesity and metabolic dysfunction often have more severe pain, greater disability, and a heavier overall symptom burden
Global guidelines from the American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD), and the American Association of Clinical Endocrinology (AACE) now recommend GLP-1 receptor agonists as preferred second-line agents after metformin in type 2 diabetes management, and increasingly as first-line in patients with established or high-risk cardiovascular disease or obesity
This ensures that any prescription of Ozempic is part of a comprehensive strategy, which includes essential lifestyle modifications like diet and exercise
A.BulutH.ShresthaP.YaparlaA.JaegerH
